XML 86 R64.htm IDEA: XBRL DOCUMENT v3.7.0.1
Guarantor Financial Information - Condensed Consolidated Statement of Cash Flows (Unaudited) (Detail) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Condensed Financial Statements Captions [Line Items]    
Net cash (used in)/provided by operating activities $ 40 $ 87
Investing activities:    
Acquisition of subsidiaries and affiliates, net of cash acquired (572) (47)
Additions to property, plant and equipment and other assets (17) (28)
Additions to intangible assets (97) (81)
Net cash used in investing activities (686) (156)
Financing activities:    
Net repayments under revolving credit facility   (164)
Repayment of debt (6) (25)
Proceeds from issuances of debt, net of issuance costs 495 496
Decrease in other short-term borrowings (5)  
Cash dividends paid to stockholders (111) (101)
Repurchase of common stock (42) (83)
Activity under stock plans 11 18
Proceeds from employee stock purchase plan 2  
Capital leases (12) (8)
Settlement of intercompany and other financing activities (3) (3)
Net cash provided by financing activities 329 130
Effect of exchange-rate changes on cash and cash equivalents 14 14
Net (decrease)/increase in cash and cash equivalents (303) 75
Cash and cash equivalents at beginning of period 754 357
Cash and cash equivalents at end of period 451 432
Parent    
Condensed Financial Statements Captions [Line Items]    
Net cash (used in)/provided by operating activities (46) (2)
Financing activities:    
Cash dividends paid to stockholders (111) (101)
Repurchase of common stock (42) (83)
Activity under stock plans 15 32
Proceeds from employee stock purchase plan 2  
Settlement of intercompany and other financing activities 186 159
Net cash provided by financing activities 50 7
Net (decrease)/increase in cash and cash equivalents 4 5
Cash and cash equivalents at beginning of period 5 1
Cash and cash equivalents at end of period 9 6
Issuers    
Condensed Financial Statements Captions [Line Items]    
Net cash (used in)/provided by operating activities 39 60
Financing activities:    
Repayment of debt (6) (25)
Proceeds from issuances of debt, net of issuance costs 495 496
Settlement of intercompany and other financing activities (511) (513)
Net cash provided by financing activities (22) (42)
Net (decrease)/increase in cash and cash equivalents 17 18
Cash and cash equivalents at beginning of period 1  
Cash and cash equivalents at end of period 18 18
Guarantor    
Condensed Financial Statements Captions [Line Items]    
Net cash (used in)/provided by operating activities 52 36
Investing activities:    
Acquisition of subsidiaries and affiliates, net of cash acquired (559) (37)
Additions to property, plant and equipment and other assets (13) (20)
Additions to intangible assets (83) (72)
Net cash used in investing activities (655) (129)
Financing activities:    
Net repayments under revolving credit facility   (164)
Activity under stock plans (4) (14)
Capital leases (12)  
Settlement of intercompany and other financing activities 359 352
Net cash provided by financing activities 343 174
Net (decrease)/increase in cash and cash equivalents (260) 81
Cash and cash equivalents at beginning of period 219 7
Cash and cash equivalents at end of period (41) 88
Non-Guarantor    
Condensed Financial Statements Captions [Line Items]    
Net cash (used in)/provided by operating activities (5) (7)
Investing activities:    
Acquisition of subsidiaries and affiliates, net of cash acquired (13) (10)
Additions to property, plant and equipment and other assets (4) (8)
Additions to intangible assets (14) (9)
Net cash used in investing activities (31) (27)
Financing activities:    
Decrease in other short-term borrowings (5)  
Capital leases   (8)
Settlement of intercompany and other financing activities (37) (1)
Net cash provided by financing activities (42) (9)
Effect of exchange-rate changes on cash and cash equivalents 14 14
Net (decrease)/increase in cash and cash equivalents (64) (29)
Cash and cash equivalents at beginning of period 529 349
Cash and cash equivalents at end of period $ 465 $ 320